Claim Your New User Special: Get your second month free ▶ Second Month Free

Serving leading biopharmaceutical companies globally:

Moodys
Boehringer Ingelheim
Johnson and Johnson
Merck
Baxter
Dow

Last Updated: May 27, 2022

Investigational Drug Information for Silicon dioxide


✉ Email this page to a colleague

« Back to Dashboard

What is the development status for investigational drug Silicon dioxide?

Silicon dioxide is an investigational drug.

There have been 7 clinical trials for Silicon dioxide. The most recent clinical trial was a Phase 3 trial, which was initiated on March 1st 2011.

The most common disease conditions in clinical trials are Renal Insufficiency, Celiac Disease, and Hypersensitivity. The leading clinical trial sponsors are German Federal Ministry of Education and Research, Florian Michel, and Autism Speaks.

Recent Clinical Trials for Silicon dioxide
TitleSponsorPhase
Celiac Disease and Vitamin Status: Evaluation of the Effect of Supplementation With a Probiotic (VIVOMIXX®) in a Cohoort of Celiac PatientsUniversity of MilanPhase 4
Probiotics for Quality of Life in Autism Spectrum DisordersAutism SpeaksEarly Phase 1
Probiotics for Quality of Life in Autism Spectrum DisordersAutism Treatment NetworkEarly Phase 1

See all Silicon dioxide clinical trials

Clinical Trial Summary for Silicon dioxide

Top disease conditions for Silicon dioxide
Top clinical trial sponsors for Silicon dioxide

See all Silicon dioxide clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
Boehringer Ingelheim
Johnson and Johnson
Merck
Baxter
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.